DOI: 10.25881/BPNMSC.2019.26.82.011

Authors

Tsitskarava A.Z., Hubulava G.G., Korolkov A.Yu., Demin A.N., Lazarev S.M.

Pavlov First Saint Petersburg State Medical University, Saint Petersburg

Abstract

Quantity of patients , who have antiplatelet or antithrombotic therapy, increases due to cardiovascular diseases rise up too. Question about complications such as rectal bleeding caused by medicamental hypocoagulation are debatable. In the research effect by antithrombotic therapy was estimated in recurrent hemorrhoidal bleeding. Basic and control groups compared and it was established relationship between antithrombotic medicines and volume of hemorrhoidal bleeding. Later study this questions need to create the algorithm for management patients with cardiovascular diseases and chronic combined hemmorhoids.

Keywords: cardiovascular diseases, cardiovascular pathology, hemorrhoids, hemorrhoids, hemorrhoidal bleeding, antiplatelet therapy, anticoagulant therapy, medicamental hypocoagulation.

References

1. Bokeriya LA, Stupakov IN, Samorodskaya IV, Botnar’ YuM. Serdechno-sosudistye zabolevaniya v Rossijskoj Federacii na rubezhe vekov: smertnost’, rasprostranennost’, faktory riska. Byulleten’ NCSSKH im. A.N. Bakuleva RAMN. 2007;8:5–11. (In Russ.).

2. SHelygin YuA. Rossijskie klinicheskie rekomendacii po diagnostike i lecheniyu vzroslyh pacientov s ostrym i hronicheskim gemorroem. M.: GEOTAR-Media, 2013. 94–98. (In Russ.).

3. SHelygin YU.A., Blagodarnyj L.A. Spravochnik koloproktologa. M.: Littera., 2012. 64–89. (In Russ.).

4. SHilov AM, Mel’nik MV, Svyatov IS. Antikoagulyanty nepryamogo dejstviya v terapevticheskoj praktike lecheniya i profilaktiki venoznogo tromboembolizma. RMZH. 2006;10:747. (In Russ.).

5. Abraham N.S. Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding. Gastrointest. Endosc. Clin. N. Am. 2015; 25: 449–62. doi: 10.1016/j.giec.2015.02.002.

6. Cea Soriano L, Lanas A, Soriano-Gabarro M. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-dose Aspirin. Clin. Gastroenterol. Hepatol. 2019;17:887–895.

7. Chen WC, Lin KH, Huang YT. The risk of lower gastrointestinal bleeding in low-dose aspirin users. Aliment. Pharmacol. Ther. 2017; 45:1542–1550. doi: 10.1111/apt.14079.

8. Kido K, Scalese MJ. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy. Ann. Pharmacother. 2017; 51:1000–1007.

9. Leong DP, Joseph PG, McKee M. et al. Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease. Cirs. Res. 2017;121: 695–710.

10. Triadafilopoulos G.Management of lower gastrointestinal bleeding in older adults. Drugs Aging. 2012; 29:707–715.

11. Qiu S, Cai X, Sun Z. Heart Rate Recovery and Risk of Cardiovascular Events and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies. J. Am. Heart Assoc. 2017;6(5) doi: 10.1161/JAHA.117.005505.

12. Qu B, Liu Q, Li J. Systematic Review of Association Between Low Ankle-Brachial Index and All Cause Cardiovascular, or Non-cardiovascular Mortality. Cell Biochem. Biophys. 2015; 73: 571–575. doi: 10.1007/s12013-015-0582-z.

For citation

Tsitskarava A.Z., Hubulava G.G., Korolkov A.Yu., Demin A.N., Lazarev S.M. Risk of hemorrhoidal bleeding in patients with cardiovascular disease. Bulletin of Pirogov National Medical & Surgical Center. 2019;14(3):56-59. (In Russ.) https://doi.org/10.25881/BPNMSC.2019.26.82.011